ArticleIn vivo (Athens, Greece)

Association Between PD-L1 Expression and Interstitial Lung Disease Risk in EGFR-mutant NSCLC Treated With EGFR-TKIs.

Yutaka Takahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.